Compounds > tributyrin
Page last updated: 2024-08-17

tributyrin and Hepatocellular Carcinoma

tributyrin has been researched along with Hepatocellular Carcinoma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andrade, FO; Farsky, SHP; Fernandes, LHG; Furtado, KS; Hebeda, CB; Heidor, R; Horst, MA; Miranda, MLP; Moreno, FS; Sandri, S; Yamamoto, RC1
Beland, FA; Campos, A; Carrilho, J; de Conti, A; Furtado, KS; Fuscoe, JC; Guariento, AH; Han, T; Moreno, FS; Pogribny, IP; Purgatto, E; Ross, SA; Shinohara, EM; Tryndyak, V1
Beland, FA; de Conti, A; Fernandes, LH; Furtado, KS; Heidor, R; Horst, MA; Moreno, FS; Ortega, JF; Pogribna, M; Pogribny, IP; Shpyleva, S; Tavares, PE; Tryndyak, V1
He, L; Ho, PC; Su, J; Zhang, N1

Other Studies

4 other study(ies) available for tributyrin and Hepatocellular Carcinoma

ArticleYear
Antiangiogenic effects of the chemopreventive agent tributyrin, a butyric acid prodrug, during the promotion phase of hepatocarcinogenesis.
    Carcinogenesis, 2019, 08-22, Volume: 40, Issue:8

    Topics: Actins; Angiogenesis Inhibitors; Animals; Apoptosis; Butyric Acid; Carcinogenesis; Carcinoma, Hepatocellular; Cell Movement; Gene Expression Regulation, Neoplastic; Hepatocytes; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Liver; Liver Neoplasms; Liver Neoplasms, Experimental; Polysaccharides; Prodrugs; Rats; Triglycerides; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2

2019
Transcriptomic responses provide a new mechanistic basis for the chemopreventive effects of folic acid and tributyrin in rat liver carcinogenesis.
    International journal of cancer, 2014, Jul-01, Volume: 135, Issue:1

    Topics: Animals; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carcinogenesis; Carcinoma, Hepatocellular; Diethylnitrosamine; Folic Acid; Gene Expression Regulation, Neoplastic; Glutathione S-Transferase pi; Humans; Liver Neoplasms; Male; Neoplasm Proteins; Neovascularization, Pathologic; Rats; Transcriptome; Triglycerides

2014
Suppressing activity of tributyrin on hepatocarcinogenesis is associated with inhibiting the p53-CRM1 interaction and changing the cellular compartmentalization of p53 protein.
    Oncotarget, 2016, Apr-26, Volume: 7, Issue:17

    Topics: Animals; Apoptosis; Butyric Acid; Carcinoma, Hepatocellular; Cell Compartmentation; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cytoplasm; Disease Models, Animal; Exportin 1 Protein; Gene Expression Regulation, Neoplastic; Humans; Karyopherins; Liver Neoplasms; Male; Protein Binding; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Triglycerides; Tumor Suppressor Protein p53

2016
Evaluation of tributyrin lipid emulsion with affinity to low-density lipoprotein: pharmacokinetics in adult male Wistar rats and cellular activity on Caco-2 and HepG2 cell lines.
    The Journal of pharmacology and experimental therapeutics, 2006, Volume: 316, Issue:1

    Topics: Algorithms; Animals; Butyrates; Caco-2 Cells; Carcinoma, Hepatocellular; Cell Line, Tumor; DNA Fragmentation; Fat Emulsions, Intravenous; Humans; Male; Protein Binding; Rats; Rats, Wistar; Receptors, LDL; Triglycerides

2006